Kenisha Shawnta Pemberton, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 4430 Missouri Ave, Fort Leonard Wood, MO 65473 Phone: 573-596-0417 |
Jack Fennel, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 126 Missouri Ave, Fort Leonard Wood, MO 65473 Phone: 573-329-8305 Fax: 573-329-8302 |
Dr. Lyman Kelton Henson, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 126 Missouri Ave, Fort Leonard Wood, MO 65473 Phone: 573-596-1680 Fax: 573-596-0423 |
Kristen Anne Tobin, MD Family Medicine Medicare: Medicare Enrolled Practice Location: General Leonard Wood Army Community Hospital, 4430 Missouri Avenue, Fort Leonard Wood, MO 65473 Phone: 573-596-1765 Fax: 573-596-0836 |
Christine Strange, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 4430 Missouri Ave # 1267, Fort Leonard Wood, MO 65473 Phone: 573-596-1765 |
John Ballentine, Family Medicine Medicare: Medicare Enrolled Practice Location: 4430 Missouri Ave, Fort Leonard Wood, MO 65473 Phone: 573-596-1600 |
Dr. Nicholas Kohles, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 4430 Missouri Ave, Fort Leonard Wood, MO 65473 Phone: 573-596-0417 |
Heather Marie Samaniego Carboni, FNP-BC Family Medicine Medicare: Medicare Enrolled Practice Location: 18 Sibert Ln, Fort Leonard Wood, MO 65473 Phone: 609-634-7748 |
Jerry P Seiler, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 4430 Missouri Ave, Fort Leonard Wood, MO 65473 Phone: 573-596-0415 |
Dr. Laura A Tavernier, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 4430 Missouri Ave, Fort Leonard Wood, MO 65473 Phone: 573-596-0417 |
Dr. Paige White, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 4430 Missouri Ave # 1267, Fort Leonard Wood, MO 65473 Phone: 573-596-0035 |
News Archive
Angiotech Pharmaceuticals, Inc. has announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its innovative 5-Fluorouracil-coated (5-FU) Central Venous Catheter (CVC) in the United States.
Speaker Nancy Pelosi issued the following statement today after the Senate Finance Committee voted to pass the committee's health insurance reform proposal.
GeoVax Labs, Inc., an Atlanta-based biopharmaceutical company, today announced that it has filed a registration statement on Form S-1 with the U.S. Securities Commission for a best efforts offering to sell up to $40.0 million of units consisting of one share of common stock and a warrant to purchase 0.20 shares of common stock. The offering anticipates including shares of common stock to be sold by selling stockholders.
Australia has seen an increase in coronavirus disease (COVID-19) cases, and this will continue for weeks despite strict border control measures, experts say. With 116 confirmed cases and thousands of people waiting to be tested, Australian hospitals could be overwhelmed by thousands of patients.
› Verified 6 days ago